X-Guide Surgical Navigation System
X-Nav Technologies, LLC • Dental • 02/21/2024
Device Purpose
The X-Guide Surgical Navigation System provides real-time, image-guided assistance for dental implantation and endodontic procedures by tracking surgical instruments relative to patient CT data with sub-millimeter accuracy. Its integration of machine learning-based Automatic Image Processing (AIP) enhances preoperative planning through automated anatomical segmentation (e.g., teeth, bone, nerves) and registration from CT and IntraOral Scans, aiming to improve workflow efficiency.
Summary
The X-Guide Surgical Navigation System is a computerized tool designed to assist dental surgeons in both the preoperative planning and intra-operative execution of dental implantation and endodontic access procedures. It employs video technology with stereo cameras and 2D barcode trackers on the handpiece and patient to precisely monitor the surgical instrument's position and movement relative to the patient's anatomy, which is pre-planned using CT scan data; the system demonstrates a positional accuracy (RMS) of less than 1mm. This system provides real-time, three-dimensional visual guidance, displaying the instrument's location in relation to the planned trajectory and critical anatomical structures, aiming to enhance surgical precision and reduce risks to adjacent tissues, supported by various patient-specific calibration methods adaptable across different clinical scenarios. A key enhancement to the X-Guide system is the integration of Automatic Image Processing (AIP) software, IconiX, which utilizes a pre-trained, non-adaptive machine learning model whose outputs (segmentations and visualizations) have been validated. This software automatically segments and identifies anatomical structures such as teeth (including roots), maxilla/mandible bone, maxillary sinuses, and the mandibular nerve canal from maxillofacial CT scans, as well as teeth and gingiva from IntraOral Scans (IOS). The AIP functionality streamlines preoperative planning by automating tasks like pan curve creation, registration of IOS to CT data, and the generation of surface models (SurfiX) for registration, all while preserving the original scan data and allowing surgeon oversight and modification, without altering the core navigation process or system hardware.
AI Regulatory Concerns
Powered by
Jev reads the full FDA letter and returns calibrated concern probabilities per regulatory category. These are AI estimates, not regulatory advice.
Keywords
Device Metadata
Relevant Clinical Questions
- Q1. How does the performance (accuracy, processing time) of the machine learning-based Automatic Image Processing (AIP) for anatomical segmentation compare to manual segmentation by experienced clinicians across diverse patient anatomies and CT/IOS image qualities?; What is the validation process for the "locked" machine learning model's segmentation accuracy, especially concerning atypical anatomies or low-quality input scans, and how frequently is the model reviewed for potential updates based on new data or evolving clinical needs?; Beyond the currently identified anatomical structures, what is the roadmap for expanding the AIP's capabilities to segment other clinically relevant features (e.g., different bone densities, pathological lesions) within maxillofacial CT/IOS data?; How does the automated IOS-to-CT registration by the AIP compare in terms of accuracy and reliability to traditional manual point-matching methods, particularly in challenging cases like extensive metal artifacts or limited common anatomical features?; What impact does the integration of AIP-driven features (pan curve creation, SurfiX generation) have on the overall workflow efficiency and the learning curve for surgeons new to the X-Guide system?
Risk Classification
ESL AnalysisFDA Class II via 510(k) pathway; IEC 62304 Class A (software safety classification); Post-§524B but no clear network capability detected
Learn how Parasoft automates IEC 62304 compliance testing →Cybersecurity Evidence
Powered by SBOMator™Based on AI-generated device summaries, not the full FDA submission. Items not detected here may still be present in the complete submission package.
Supply Chain BOM Evidence
Based on the CycloneDX / OWASP ECMA-424 xBOM ecosystem. Detection is from the AI-generated summary.
Analysis:
• Analysis is based on the AI-generated device summary, not the full FDA submission package. Click "Analyze Full FDA PDF" below to scan the actual submission document.
• Evidence of ML-BOM, HBOM detected in AI-generated device summary.
• SBOM not mentioned in AI-generated device summary. Under §524B (effective Oct 2023), cyber devices must provide a SBOM.
• Cybersecurity risk assessment not referenced in AI-generated device summary. FDA cybersecurity guidance (2023) expects this for cyber devices.
• Postmarket cybersecurity monitoring plan not clearly documented in AI-generated device summary.
• Not detected in AI-generated device summary: SBOM, SaaSBOM, CBOM, VDR/VEX, OBOM. These may be present in the full FDA submission.
Preparing a similar submission?
ESL takes complete ownership of your software evidence work - SBOM & CVE remediation with SBOMator™, static analysis & unit testing with Parasoft, traceability, and full IEC 62304 lifecycle support.
Assess Your Readiness →Or contact ESL directly